Related Experiment Video
Updated: Oct 18, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Management and outcome of extreme pediatric obstructive sleep apnea
Tatyana G Mills1, Rakesh Bhattacharjee2, Javan Nation3
1Department of Pediatrics, University of California San Diego, Rady Children's Hospital San Diego, 3030 Children's Way, San Diego, CA, 92123, USA.
Insights
Children with extreme obstructive sleep apnea (OSA) undergoing adenotonsillectomy (AT) may require respiratory support post-surgery. However, AT is safe and effective, with no serious harm reported, making it a viable first-line treatment for extreme OSA.
Area of Science:
- Pediatric Otolaryngology
- Sleep Medicine
- Respiratory Physiology
Background:
- Extreme obstructive sleep apnea (OSA) presents unique challenges in pediatric surgical management.
- Adenotonsillectomy (AT) is a common treatment for OSA, but risks in severe cases require careful evaluation.
Purpose of the Study:
- To classify the need for post-adenotonsillectomy (AT) respiratory support in children with extreme obstructive sleep apnea (OSA).
- To identify predictors for respiratory interventions after AT in this population.
- To evaluate the outcomes of AT in children diagnosed with extreme OSA.
Main Methods:
- Retrospective chart analysis of pediatric patients with an apnea/hypopnea index (AHI) > 100 events/h.
- Exclusion of patients with chronic diseases other than obesity.
- Analysis of demographic, polysomnographic (PSG), and postoperative data.
Main Results:
- Twenty-eight of 41 subjects (68.3%) underwent AT; 39.3% required postoperative respiratory support.
- Factors predicting respiratory support included longer time with SpO2 <90% and lower SpO2 nadir during PSG.
- No mortality, reintubation, or readmission occurred; 57.9% had residual OSA post-AT, but significant AHI improvement was noted.
Conclusions:
- Postoperative observation is crucial for children with extreme OSA undergoing AT.
- Despite a higher risk of respiratory support needs, AT is safe, with no severe adverse events.
- Adenotonsillectomy can be considered a primary treatment for selected children with extreme OSA.
Objectives:
Classify post-adenotonsillectomy (AT) respiratory support, identify variables that predict these interventions, and evaluate outcomes in children with extreme obstructive sleep apnea (OSA).
Methods:
Retrospective chart analysis was performed on patients found to have apnea/hypopnea index (AHI) > 100 events/h. Patients with chronic diseases other than obesity were excluded.
Results:
Forty-one subjects were studied, average age of 11.4 ± 4.3 years, majority (73.1%) were Hispanic, with a mean total AHI (TAHI) of 128.1 ± 22.9/h. Twenty-eight (68.3%) patients underwent AT. Lower age (P < 0.001), lower BMI Z-score (P < 0.01), higher OAHI (P < 0.05) were associated with having surgery. Eleven out of 28 (39.3%) surgical patients required respiratory support (oxygen or positive airway pressure) postoperatively. Longer % total sleep time SpO2 <90% during PSG (P < 0.05) and lower SpO2 nadir (P < 0.05) were associated with requiring airway support. No patients experienced mortality, reintubation, or hospital readmission following AT, with majority (71.4%) discharged 1 day post-operatively. Eleven (57.9%) of the 19 patients who had a postoperative PSG had residual OSA, defined as AHI >5 events/h, but there was a significant improvement in TAHI (P < 0.01).
Conclusion:
Our findings confirm the need for postoperative observation in a controlled setting for patients with extreme OSA undergoing AT. Although at higher risk of needing respiratory support, those patients undergoing AT for extreme OSA did not require re-intubation post-operatively or suffer serious harm. Barring contraindications to AT, surgery may still be a first-line therapy for some children with extreme OSA.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Cardiopulmonary Resuscitation II: ACLS Airway Management
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Acute Respiratory Failure-III
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

